{
  "title": "Predictive power of tertiary lymphoid structure for prognosis and neoadjuvant chemotherapy response in HER2-positive breast cancer.",
  "pmid": "40489875",
  "doi": null,
  "affiliations": [
    "Department of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.",
    "Clinical Research Center for Breast Cancer in Hunan Province, Changsha, Hunan, China.",
    "Department of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.",
    "Clinical Research Center for Breast Cancer in Hunan Province, Changsha, Hunan, China.",
    "Department of Clinical Medicine, Queen Marry School, Nanchang University, Nanchang, Jiangxi, China.",
    "Department of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.",
    "Clinical Research Center for Breast Cancer in Hunan Province, Changsha, Hunan, China.",
    "Center for Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China.",
    "Department of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.",
    "Clinical Research Center for Breast Cancer in Hunan Province, Changsha, Hunan, China."
  ]
}